Abstract
Background
Evidence suggests that substance abuse negatively affects both psychiatric symptom severity and quality of life (QOL) in people with severe mental illness (SMI). However, these relationships have not been examined simultaneously, nor have they been characterized over time. Thus, it is difficult to appreciate the extent to which substance abuse exerts an enduring effect on psychiatric symptoms and distress and/or QOL in this population. The purpose of this study is to test a conceptual model linking these factors together.
Methods
Subjects were participants in a longitudinal evaluation of community mental healthcare in Ontario (n = 133). Comprehensive consumer assessments were conducted at treatment entry, and at 9 and 18 months. Subjects were receiving intensive case management or assertive community treatment throughout the 18-month study period. Structural equation modelling was used to examine the concurrent and longitudinal relationships between substance abuse, symptoms and distress, and QOL.
Results
The prevalence of substance abuse was 55.0%. The SEM analysis suggested that substance abuse at baseline was associated with elevated symptomatology and distress and lower QOL, and that these effects endured after 18 months of treatment. Psychiatric symptoms and distress mediated the negative relationship between substance abuse and QOL.
Conclusions
The mediating role played by symptom and distress levels in the relationship between substance abuse and QOL suggests the importance of closely monitoring changes in these factors among SMI patients with substance problems. Tracking symptom severity and distress levels over time will allow service providers to intervene and potentially improve the QOL of individuals with SMI.
Similar content being viewed by others
References
Addington J, Addington D (1997) Substance abuse and cognitive functioning in schizophrenia. J Psychiatry Neurosci 22:99–104
American Psychiatric Association (2000) Handbook of psychiatric measures. American Psychiatric Association, Washington, DC
Arbuckle JL (2003) AMOS 5. Small Waters Corp, Chicago, IL
Bellack AS, Gearon JS (1998) Substance abuse treatment for people with schizophrenia. Addict Behav 23:749–766
Bjorkman T, Hansson L (2002) Predictors of improvement in quality of life of long-term mentally ill individuals receiving case management. Eur Psychiatry 17:33–40
Blanchard JJ, Brown SA, Horan WP, et al. (2000) Substance use disorders in schizophrenia: review, integration, and a proposed model. Clin Psychol Rev 20:207–234
Byrne BM (2001) Structural equation modeling with AMOS: basic concepts, applications and programming. Lawrence Erlbaum Associates, Mahwah, NJ
Carey MP, Carey KB, Meisler AW (1991) Psychiatric symptoms in mentally ill chemical abusers. J Nerv Ment Dis 179:136–138
CMHEI Working Group (2004) Making a difference: Ontario’s Community Mental Health Initiative. http://www.ontario.cmha.ca/cmhei/making_a_difference.asp. Accessed 16 March 2005
Cocoo KM, Carey KB (1998) Psychometric properties of the Drug Abuse Screening Test in psychiatric outpatients. Psychol Assess 10:408–414
Conigrave KM, Hall WD, Saunders JB (1995) The AUDIT questionnaire: choosing a cut-off score. Addiction 90:1349–1356
Curran GM, Sullivan G, Williams K, et al. (2003) Emergency department use of persons with comorbid psychiatric and substance abuse disorders. Ann Emerg Med 41:659–667
Derogatis LR, Cleary PA (1977) Confirmation of the dimensional structure of the SCL-90. A study of construct validation J Clin Psychol 33:981–989
Dickerson FB, Ringel NB, Parente F (1998) Subjective quality of life in out-patients with schizophrenia: clinical and utilization correlates. Acta Psychiatr Scand 98:124–127
Drake RE, Osher FC, Wallach MA (1989) Alcohol use and abuse in schizophrenia: a prospective community study. J Nerv Ment Dis 177:408–414
Foster J, Powell JE, Marshall EJ, et al. (1999) Quality of life in alcohol dependent subjects: a review. Qual Life Res 8:255–261
Galletly CA, Clark CR, McFarlane AC, et al. (1997) Relationships between changes in symptom ratings, neuropsychological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiatry Res 72:161–166
Havassy BE, Arns PG (1998) Relationship of cocaine and other substance dependence to well-being of high-risk psychiatric patients. Psychiatr Serv 49:935–940
Health Canada (2002) Best practices: concurrent mental health and substance use disorders. Health Canada, Ottawa, ON
Kline RB (1998) Principles and practice of structural equation modeling. Guilford Press, New York, NY
Lehman AF (1988) A quality of life interview for the chronically mentally ill. Eval Program Plann 11:51–62
Maisto SA, Carey MP, Carey KB, et al. (2000) Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness. Psychol Assess 12:186–192
Overall JE, Gorham DR (1988) The Brief Psychiatric Rating Scale (BPRS): recent developments in ascertainment and scaling. Psychopharmacol Bull 24:97–99
Packer S, Husted J, Cohen S, et al. (1997) Psychopathology and quality of life in schizophrenia. J Psychiatry Neurosci 22:231–234
RachBeisel J, Scott J, Dixon L (1999) Co-occurring severe mental illness and substance use disorders: a review of recent research. Psychiatr Serv 50:1427–1434
Regier DA, Farmer ME, Rae DS, et al. (1990) Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA 264:2511–2518
Ritsner M, Kurs R, Gibel A, et al. (2003) Predictors of quality of life in major psychoses: a naturalistic follow-up study. J Clin Psychiatry 64:308–315
Ritsner M, Modai I, Endicott J, et al. (2000) Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J Clin Psychiatry 61:880–889
Rudnick A (2001) The impact of coping on the relation between symptoms and quality of life in schizophrenia. Psychiatry 64:304–308
Russo J, Roy-Byrne P, Reeder D, et al. (1997) Longitudinal assessment of quality of life in acute psychiatric inpatients: reliability and validity. J Nerv Ment Dis 185:166–175
Saunders JB, Aasland OG, Babor TF, et al. (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): who collaborative project on early detection of persons with harmful alcohol consumption II. Addiction 88:791–804
Schaar I, Ojehagen A (2003) Predictors of improvement in quality of life of severely mentally ill substance abusers during 18 months of cooperation between psychiatric and social services. Soc Psychiatry Psychiatr Epidemiol 38:83–87
Skinner H (1982) The drug abuse screening test. Addict Behav 7:363–371
Smith KW, Larson MJ (2003) Quality of life assessments by adult substance abusers receiving publicly funded treatment in Massachusetts. Am J Drug Alcohol Abuse 29:323–335
SPSS Inc (2003) SPSS for Windows: release 12.0.0. Author, Chicago IL
Staley D, El-Guebaly N (1990) Psychometric properties of the drug abuse screening test in a psychiatric patient population. Addict Behav 15:257–264
Strupp HH (1996) The tripartite model and the Consumer Reports study. Am Psychol 51:1017–1024
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Urbanoski, K.A., Cairney, J., Adlaf, E. et al. Substance abuse and quality of life among severely mentally ill consumers. Soc Psychiat Epidemiol 42, 810–818 (2007). https://doi.org/10.1007/s00127-007-0236-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00127-007-0236-6